WHO ICTRP trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of…
TCTR20250401006 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20250401006 |
|---|---|
| Public title | A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Empagliflozin 25 mg Film-coated Tablets (JARFLOZIN) and Reference Product (Jardiance) in Healthy Thai Volunteers under Fasting Conditions |
| Scientific title | A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Empagliflozin 25 mg Film-coated Tablets (JARFLOZIN) and Reference Product (Jardiance) in Healthy Thai Volunteers under Fasting Conditions |
| Primary sponsor | International Bio Service Co., Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Thailand |
| Conditions | Bioequivalence study in healthy Thai male volunteers Empagliflozin 25 mg Film-coated Tablets (JARFLOZIN) and Reference Product (Jardiance) in Healthy Thai Volunteers under Fasting Conditions;Empagliflozin 25 mg Film-coated Tablets… |
| Interventions | Each tablet contains 25 mg of empagliflozin. Single dose study with washout period at least 7 days,Each tablet contains 25 mg of empagliflozin. Single dose study with washout period at least 7 days;Experimental Drug,Active Comparator… |
| Registration date | Jan 4, 2025 |
| Target size | 30 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: